An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
NeoGenomics, Inc. (NASDAQ: NEO) to present at the 42nd Annual J.P. Morgan Healthcare Conference
Positive
None.
Negative
None.
FT. MYERS, Fla.--(BUSINESS WIRE)--
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
Members of NeoGenomics’ management team will deliver a presentation followed by Q&A on Monday, January 8th at 5:15 p.m. PT/8:15 p.m. ET. A live and archived audio webcast of the presentation will be available on the “News, Events, and Webcasts” tab via the Investor Relations section of the Company’s website at ir.neogenomics.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. The Company's Advanced Diagnostic Division also serves pharmaceutical clients in clinical trials and drug development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories for full-service sample processing in Fort Myers, Florida; Aliso Viejo and San Diego, California; Research Triangle Park, North Carolina; and Houston, Texas; and a CAP accredited full-service, sample-processing laboratory in Cambridge, United Kingdom. NeoGenomics also has several, small, non-processing laboratory locations across the United States for providing analysis services. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
What is the latest announcement from NeoGenomics, Inc. (NASDAQ: NEO)?
NeoGenomics, Inc. (NASDAQ: NEO) will participate in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
When will the presentation take place at the 42nd Annual J.P. Morgan Healthcare Conference?
The presentation by NeoGenomics, Inc. (NASDAQ: NEO) will take place on Monday, January 8th at 5:15 p.m. PT/8:15 p.m. ET.
Where can I access the live and archived webcast of the presentation by NeoGenomics, Inc. (NASDAQ: NEO)?
The live and archived audio webcast of the presentation will be available on the 'News, Events, and Webcasts' tab via the Investor Relations section of the Company’s website at ir.neogenomics.com.
